Company intelligence / Profile preview
Handok
Seoul, Seoul, South Koreahandok.co.kr ↗
- Ownership
- Public · 002390
- Employees
- ~550
- Development stage
- Commercial
01
Overview
Handok has a robust commercial portfolio including both prescription and OTC drugs. It has several approved drugs for diabetes (e.g., Amaryl MEX), oncology (Pemigatinib for cholangiocarcinoma), allergy treatment (Fexofenadine Hydrochloride), hematology/oncology biologics such as Tafasitamab-Cxix for lymphoma. The company also develops medical devices and diagnostics. Recent clinical highlights include positive Phase 2/3 results from its collaborator Compass Therapeutics on Tovecimig for cancer immunotherapy and ongoing late-stage trials with affiliates like Rezolute in rare metabolic diseases[1].
- Therapeutic areas
- OncologyEndocrinologyImmunologyHematology
- Modalities
- Small moleculesbispecific antibodiesFc fragmentssynthetic peptides
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Teva Pharmaceutical Industries Ltd. [TEVA-HANDOK JV]Sobi [Sobi-Handok JV]Sanofi/Aventis [historic partnership—Amaryl export/manufacture continues]Compass Therapeutics [cancer immunotherapy collaboration]
Beyond the preview
Go deeper on Handok.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Handok.